ProMIS Neurosciences, Inc.
PMN
$0.50
$0.0122.46%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 8.55M | 8.52M | 6.42M | 5.00M | 4.38M |
| Gross Profit | -8.55M | -8.52M | -6.42M | -5.00M | -4.38M |
| SG&A Expenses | 3.13M | 2.69M | 6.16M | 5.67M | 6.47M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.11M | 13.33M | 14.70M | 12.78M | 12.97M |
| Operating Income | -17.11M | -13.33M | -14.70M | -12.78M | -12.97M |
| Income Before Tax | -934.00K | 2.78M | -563.40K | -12.20M | -11.89M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.93 | 2.78 | -0.56 | -12.20 | -11.89 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -934.00K | 2.78M | -563.40K | -12.20M | -11.89M |
| EBIT | -17.11M | -13.33M | -14.70M | -12.78M | -12.97M |
| EBITDA | -9.64M | -13.31M | -14.67M | -12.75M | -12.94M |
| EPS Basic | -0.04 | -0.02 | -0.19 | -0.69 | -0.83 |
| Normalized Basic EPS | 0.04 | 0.05 | -0.12 | -0.43 | -0.52 |
| EPS Diluted | -0.04 | -0.02 | -0.19 | -0.69 | -0.83 |
| Normalized Diluted EPS | 0.04 | 0.05 | -0.12 | -0.43 | -0.52 |
| Average Basic Shares Outstanding | 119.46M | 104.15M | 88.91M | 71.26M | 60.07M |
| Average Diluted Shares Outstanding | 119.51M | 104.19M | 88.96M | 71.26M | 60.07M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |